The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...
Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The Centers for Medicare and Medicaid Services (CMS) listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top of its list of drugs selected for Medicare negotiation in 2025.
Medicare, the national health program for nearly all Americans 65 and older, was created in 1965. As the program evolves, ...
At the top of the list is Novo Nordisk's blockbuster diabetes ... the 25 products represent 36% of all Medicare Part D prescription drug costs during that time period, the release said.